Globe Life (GL) Stock Price, News & Analysis

Company Overview

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

Key Stats

• Today's Range: $135.31 to $139.58
• 50-Day Range: $117.52 to $143.21
• 52-Week Range: $86.10 to $144.00
• Volume: 756,639 shs
• Average Volume: 757,545 shs
• Market Capitalization: $11.32 billion
• P/E Ratio: 10.97
• Dividend Yield: 0.79%
• Price Target: $149.18
• Consensus Rating: Moderate Buy

Globe Life Stock Analysis - MarketRank™

Globe Life scored higher than 94% of companies evaluated by MarketBeat, and ranked 121st out of 919 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Globe Life has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Globe Life has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.36%

Earnings Growth

Earnings for Globe Life are expected to grow by 8.36% in the coming year, from $13.87 to $15.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Globe Life is 10.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.10.

Price to Earnings Ratio vs. Sector

The P/E ratio of Globe Life is 10.97, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.75.

Price to Book Value per Share Ratio

Globe Life has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.61% of the float of Globe Life has been sold short.

Short Interest Ratio / Days to Cover

Globe Life has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Globe Life has recently decreased by 3.65%, indicating that investor sentiment is improving.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Globe Life has a dividend yield of 0.77%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Globe Life has been increasing its dividend for 20 years.

Dividend Coverage

The dividend payout ratio of Globe Life is 8.63%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Globe Life will have a dividend payout ratio of 7.19% next year. This indicates that Globe Life will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.0 / 5
• Environmental Score: -0.21

Percentage of Shares Shorted

1.61% of the float of Globe Life has been sold short.

Short Interest Ratio / Days to Cover

Globe Life has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Globe Life has recently decreased by 3.65%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.64

News Sentiment

Globe Life has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 26 news articles for Globe Life this week, compared to 14 articles on an average week.

Search Interest

Only 4 people have searched for GL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

2 people have added Globe Life to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Globe Life insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,097,080.00 in company stock.

Percentage Held by Insiders

Only 1.51% of the stock of Globe Life is held by insiders.

Percentage Held by Institutions

81.61% of the stock of Globe Life is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GL Stock Analysis - Frequently Asked Questions

How have GL shares performed this year?

Globe Life's stock was trading at $111.52 at the start of the year. Since then, GL stock has increased by 23.0% and is now trading at $137.18.

How were Globe Life's earnings last quarter?

Globe Life Inc. (NYSE:GL) announced its quarterly earnings data on Wednesday, July, 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life's quarterly revenue was up 2.9% on a year-over-year basis.
Read the conference call transcript.

Who are Globe Life's major shareholders?

Globe Life's top institutional shareholders include Pzena Investment Management LLC (1.15%), Nordea Investment Management AB (1.02%), Leith Wheeler Investment Counsel Ltd. (0.80%) and Livforsakringsbolaget Skandia Omsesidigt (0.28%). Insiders that own company stock include Larry M Hutchison, Melissa Jane Buchan, Jane Buchan, James Matthew Darden, Robert Brian Mitchell, Michael Clay Majors, Frank M Svoboda, Thomas Peter Kalmbach, Kenneth J Matson, Robert W Ingram, Mary E Thigpen, Jennifer Allison Haworth, Rebecca E Zorn, Steven John Dichiaro, Robert Edward Hensley, Cheryl Alston, Dolores L Skarjune, David A Rodriguez, Michael Shane Henrie, Jason A Harvey, John Henry Rogers, Jr and David Kendall Carlson.
View institutional ownership trends.

How do I buy shares of Globe Life?

Shares of GL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Globe Life own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Globe Life investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), SPDR S&P 500 ETF Trust (SPY), Advanced Micro Devices (AMD), Exxon Mobil (XOM) and Tesla (TSLA).

Company Calendar

• Record date for 8/1 Dividend: 7/03/2025
• Ex-Dividend for 8/1 Dividend: 7/03/2025
• Last Earnings: 7/23/2025
• Dividend Payable: 8/01/2025
• Today: 8/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: INS - ACC & HLTH
• Sub-Industry: Insurance
• Current Symbol: NYSE:GL
• CIK: 320335
• Web: www.globelifeinsurance.com
• Phone: (972) 569-4000
• Fax: 972-569-3282
• Employees: 3,732
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Globe Life: $149.18
• High Price Target: $188.00
• Low Price Target: $114.00
• Potential Upside/Downside: +8.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.82
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $12.51
• Trailing P/E Ratio: 10.97
• Forward P/E Ratio: 9.89
• P/E Growth: N/A
• Net Income: $1.07 billion
• Net Margins: 18.11%
• Pretax Margin: 22.42%
• Return on Equity: 21.55%
• Return on Assets: 3.75%

Debt

• Debt-to-Equity Ratio: 0.43
• Current Ratio: 0.07
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $5.78 billion
• Price / Sales: 1.96
• Cash Flow: $17.68 per share
• Price / Cash Flow: 7.76
• Book Value: $63.20 per share
• Price / Book: 2.17

Miscellaneous

• Outstanding Shares: 82,540,000
• Free Float: 81,297,000
• Market Cap: $11.32 billion
• Optionable: Optionable
• Beta: 0.56